HIF1A and non-small cell lung carcinoma: Strikingly, we found a subset of non-small cell lung (NSCLC) tumors (39%, RASSF1Ahigh) showing an upregulation of RASSF1A expression, along with co-localization with HIF-1α and increased hypoxic signatures (LDHA, CA) expression.